FIG · Figma, Inc.

The thesis

Figma's recovery case remains unproven, and the Q3 2026 report, expected 4 November 2026, settles whether cheaper artificial intelligence (AI) credits still leave revenue and margins intact. The shares closed at $22.98 on 27 October 2026, up from $21.48 on 14 October 2026, and 56.8% below the 52-week high of $53.14 (adjusted daily closes).

Figma has reported no results since 5 August 2026, so the business evidence is unchanged. June-quarter revenue was $370.083 million, up 48% year over year, with net dollar retention of 136%. Q3 revenue guidance is $373.0 million to $375.0 million. Earnings-calendar sites cite a consensus revenue estimate of $376.6 million and a loss of $0.22 per share for the quarter, above the top of the guidance range. The company had not published a press release confirming the report date as of 28 October 2026.

Stifel kept a Hold rating and cut its target to $22 on 14 October 2026. Wells Fargo kept Overweight and cut its target to $30 on 13 October 2026 (Benzinga analyst actions). The latest close sits above Stifel's target.

The narrative is maturing: the AI-winner story has been well known since Bank of America reinstated coverage with a Buy rating and a $30 target on 7 July 2026, and the news since then has been target cuts and the 6 October 2026 release of Figma Agent from beta.

Bullish and bearish views on Figma, Inc.

The bull case on Figma, Inc. (FIG), in brief: Growth is still high. The bear case: Cheaper credits cloud the revenue model.

Bull case

• Growth is still high. Revenue rose 48% year over year to $370.1 million in the June quarter, with net dollar retention of 136% (company results, 5 August 2026). Existing customers were expanding spending at the last report.
• Large-customer count is rising. At 30 June 2026 the company had 1,635 customers above $100,000 in annual recurring revenue, up 46% year over year (company results, 5 August 2026).
• Product has left beta. Figma announced on 6 October 2026 that Figma Agent is out of beta, which gives the Q3 report a wider-release usage line to show.
• Targets sit above the price. Wells Fargo's target is $30 with an Overweight rating (13 October 2026). MarketBeat showed 14 firms with an average target of $32.56 and a high of $42 on 29 September 2026.
• Shares have recovered from the October low. The close rose from $21.48 on 14 October 2026 to $22.98 on 27 October 2026, and the 14-day relative strength index (RSI) is 56.8 (adjusted daily closes).

Bear case

• Cheaper credits cloud the revenue model. CEO Dylan Field said on 8 September 2026 that credit costs fell, in some cases by half, and named usage volume as the goal. No reported figure yet shows usage rising enough to offset the lower price.
• Growth guidance is slow. The Q3 revenue guide of $373.0 million to $375.0 million sits barely above Q2's $370.083 million (company results, 5 August 2026).
• Analysts are trimming targets. Stifel cut to $22 on 14 October 2026 and Wells Fargo cut to $30 on 13 October 2026, ahead of the report.
• Reported profit is adjusted profit. Q2 2026 non-GAAP operating income was $36.1 million, while the operating loss under generally accepted accounting principles (GAAP) was $117.3 million, after $147.6 million of stock-based compensation.
• Insiders have been selling. MarketBeat reported 1.33 million shares worth about $34.6 million sold by insiders over the three months to 29 September 2026.
• Coverage is cool. MarketBeat listed four Buy, nine Hold and one Sell rating on 29 September 2026.

Price setup

The adjusted close was $22.98 on 27 October 2026. The shares are down 3.3% over three months and 56.8% below the 52-week high of $53.14. The 14-day RSI is 56.8, a neutral reading.

The late-September trading area near $20.25 and the $20.00 round number are the nearest support levels the prior note identified. The close is about 15% above the $20.00 level. Moving-average readings in the last note came from MarketBeat on 29 September 2026, when the 50-day average was $24.41 and the 200-day $22.28, and they are not refreshed here.

Crowding evidence is mixed. An earnings date is about a week away, and the last published short interest was 66.09 million shares as of 15 July 2026 (ts2.tech), which is stale. Insider sales over the three months to 29 September 2026 are the one measured supply figure.

Catalysts, next 30 days

• ~4 November 2026, est.: Q3 2026 earnings report. Earnings calendars list Wednesday 4 November 2026 after the close, and one source listed 11 November 2026. It tests the $373.0 million to $375.0 million revenue guide, the 85% non-GAAP gross margin and the 136% net dollar retention after the credit price cuts.

Elapsed catalysts

• Before the report: analyst target changes. Further cuts or upgrades would update the consensus range, which ran from $22 to $42 on 29 September 2026. (passed 38d ago)

What would change the view

The case breaks if the Q3 report shows revenue below the $373.0 million guidance floor or non-GAAP gross margin below the June quarter's 85%, since either would show lower credit prices costing more than usage adds. A weaker net dollar retention figure than 136% would point the same way.

A daily close below $20.00, under the late-September trading area near $20.25, would also end the case. Revenue above the $376.6 million consensus with margins held at 85% or better would strengthen it.

What it trades with

Figma trades with growth software and with the debate over whether AI tools erode or extend design and collaboration software. Benzinga coverage in July linked its moves to sector sentiment on software and to analyst resets. Its stock has also been grouped with recent large IPOs such as Circle (Benzinga, 11 July 2026). Multi-class share structure distorts float and supply math.